Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Endoscopic Retrograde Cholangiopancreatography, Endoscopic Ultrasound and Interventional Endoscopy in Pancreatico-biliary, Gastrointestinal and Esophageal Disorders

NCT01438385 is registered in ClinicalTrials.gov with Weill Medical College of Cornell University as lead sponsor.

NCT NCT01438385
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01438385 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Endoscopic Retrograde Cholangiopancreatography, Endoscopic Ultrasound and Interventional Endoscopy in Pancreatico-biliary, Gastrointestinal and Esophageal Disorders
Lead sponsor
Weill Medical College of Cornell University
Phase
Observational
Overall status
Unknown status
Start date
July 31, 2011
Completion date
December 30, 2017
Enrollment
12,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute and chronic pancreatitis, ampullary cancer, barrett's esophagus, bile duct cancer, bile duct disorders, bile leak, biliary and pancreatic stones, biliary strictures, cholangiocarcinoma, cholangitis, choledocholithiasis, colorectal cancer, duodenal cancer, esophageal cancer, gallstones, gastric malignancies, obstructive jaundice, pancreatic cancer, pancreatic disorders (noncancerous), pancreatic divisum, pancreatic pseudocysts, pediatric gastroenterology, recurrent pancreatitis